ロード中...
Breakthrough venous thromboembolic events in five patients with COVID‐19 on direct oral anticoagulants
WHAT IS KNOWN AND OBJECTIVE: Coronavirus disease 2019 (COVID‐19) is associated with increased risk of venous thromboembolism (VTE). Guidance for VTE prophylaxis continues to evolve, including addressing direct oral anticoagulants (DOACs) continued upon hospitalization. CASE SUMMARIES: We present 5 p...
保存先:
| 出版年: | J Clin Pharm Ther |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753371/ https://ncbi.nlm.nih.gov/pubmed/33217032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcpt.13311 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|